title: Apixaban, sodium picosulfate, and regorafenib.
authors.affiliation: Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, USA.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Koval
mesh_terms: D002951:Citrates / Q000627:therapeutic use*; D006801:Humans; D009942:Organometallic Compounds / Q000627:therapeutic use*; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D010847:Picolines / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D011728:Pyridones / Q000627:therapeutic use*
chemical_list: D002951:Citrates; D009942:Organometallic Compounds; D010671:Phenylurea Compounds; D010847:Picolines; D011720:Pyrazoles; D011725:Pyridines; D011728:Pyridones; C559147:regorafenib; C522181:apixaban; C005701:picosulfate sodium